Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Martikainen, A.
Right arrow Articles by Akerblom, H. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Martikainen, A.
Right arrow Articles by Akerblom, H. K.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes, Vol 45, Issue 12 1706-1710, Copyright © 1996 by American Diabetes Association


ARTICLES

Disease-associated antibodies in offspring of mothers with IDDM

A Martikainen, T Saukkonen, PK Kulmala, H Reijonen, J Ilonen, K Teramo, P Koskela, M Knip and HK Akerblom
Department of Pediatrics, University of Oulu, Finland.

We studied 20 infants of mothers with IDDM participating in a pilot study for a dietary intervention trial, testing the hypothesis that avoidance of cow's milk proteins early in life will reduce the risk of subsequent IDDM. The aim was to evaluate the elimination of IDDM-associated antibodies from the peripheral circulation of the infants, the possible emergence of autoantibodies indicating beta-cell destruction, and the influence of the dietary intervention and genetic disease susceptibility on the development of these autoantibodies. Transplacentally transferred islet cell antibodies (ICAs) and antibodies to the 65-kDa isoform of glutamic acid decarboxylase (GAD65As) disappeared from the peripheral circulation of most infants over the first few months of life and in all infants before the age of 9 months. Insulin antibodies were eliminated before the same age in all cases but one. The higher the initial antibody level was, the longer the time required for elimination. Four infants tested positive for insulin autoantibodies (IAAs) on at least one occasion during the first year of life, and 5 out of 16 unaffected subjects (31%) had IAAs at the age of 2 years. One infant became positive for IAA before the age of 6 months, with increasing levels later, seroconverted to positivity for ICAs and GAD65As between 6 and 9 months and presented with clinical IDDM at the age of 14 months. He had the HLA DQB1*0302/x genotype, which predisposes carriers to IDDM, and had been given the casein hydrolysate formula as supplementary milk. There were no significant differences in the levels of various autoantibodies between two groups of subjects defined either on the type of dietary intervention or the degree of genetic susceptibility. The findings indicate that transplacentally transferred antibodies related to IDDM are usually eliminated from the peripheral circulation of infants before 9 months of age and that IDDM-associated autoantibodies may emerge before the age of 6 months. Our results also illustrate that avoidance of cow's milk proteins over the first 9 months of life does not provide total protection against IDDM.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Diabetes CareHome page
H. M. Stanley, J. M. Norris, K. Barriga, M. Hoffman, L. Yu, D. Miao, H. A. Erlich, G. S. Eisenbarth, and M. Rewers
Is Presence of Islet Autoantibodies at Birth Associated With Development of Persistent Islet Autoimmunity?: The Diabetes Autoimmunity Study in the Young (DAISY)
Diabetes Care, February 1, 2004; 27(2): 497 - 502.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
T. Kimpimaki, A. Kupila, A.-M. Hamalainen, M. Kukko, P. Kulmala, K. Savola, T. Simell, P. Keskinen, J. Ilonen, O. Simell, et al.
The First Signs of {beta}-Cell Autoimmunity Appear in Infancy in Genetically Susceptible Children from the General Population: The Finnish Type 1 Diabetes Prediction and Prevention Study
J. Clin. Endocrinol. Metab., October 1, 2001; 86(10): 4782 - 4788.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
H. E. Naserke, E. Bonifacio, and A.-G. Ziegler
Prevalence, Characteristics and Diabetes Risk Associated with Transient Maternally Acquired Islet Antibodies and Persistent Islet Antibodies in Offspring of Parents with Type 1 Diabetes
J. Clin. Endocrinol. Metab., October 1, 2001; 86(10): 4826 - 4833.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A.-M. HÄmäläinen, M. S. Ronkainen, H. K. Åkerblom, and M. Knip The Finnish TRIGR Study Group
Postnatal Elimination of Transplacentally Acquired Disease-Associated Antibodies in Infants Born to Families with Type 1 Diabetes
J. Clin. Endocrinol. Metab., November 1, 2000; 85(11): 4249 - 4253.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
E. Bonifacio, M. Scirpoli, K. Kredel, M. Fuchtenbusch, and A.-G. Ziegler
Early Autoantibody Responses in Prediabetes Are IgG1 Dominated and Suggest Antigen-Specific Regulation
J. Immunol., July 1, 1999; 163(1): 525 - 532.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 1996 by the American Diabetes Association.